Breaking News Instant updates and real-time market news.

2019-11-13 11:33:35 V Visa $179.73 -0.06 (-0.03%) , MA MasterCard $279.01 1.9 (0.69%) 11:33 11/13/19 11/13 11:33 11/13/19 11:33	FTC probing Visa, MasterCard over debit card transactions, Bloomberg reports The Federal Trade Commission, as part of a preliminary inquiry, has been reaching out to large merchants and their trade groups over Visa's (V) and Mastercard's (MA) policies that can prohibit merchants from routing card transactions over alternative debit networks, Jenny Surane of Bloomberg reports, citing people with knowledge of the matter. At issue is whether Visa and Mastercard and large debit card issuers are blocking retailers from routing some mobile wallet payments and tap-to-pay transactions over alternative networks such as Pulse, NYCE and Star, sources told Bloomberg. V Visa $179.73 -0.06 (-0.03%) MA MasterCard $279.01 1.9 (0.69%)	10 Dec
V MA V Visa $179.73 -0.06 (-0.03%) 10/25/19 JEFF 10/25/19 NO CHANGE Target $210 JEFF Buy Visa setup attractive for 2020, says Jefferies Visa reported a 3% earnings beat relative to consensus driven by top-line upside and a lower tax rate, Jefferies analyst Trevor Williams tells investors in a research note. The analyst views the company's fiscal 2020 guide as better than some feared and believes it implies continued momentum from the second half of 2019 through 2020. He continues to like the near-term setup for the shares and keeps a Buy rating on the name with a $210 price target. 10/28/19 BMOC 10/28/19 NO CHANGE Target $239 BMOC Outperform Visa price target raised to $239 from $231 at BMO Capital BMO Capital analyst James Fotheringham raised his price target on Visa to $239 and kept his Outperform rating after its Q4 earnings beat and encouraging FY20 guidance driven by improved incentives, reduced operating costs, and lower assumed tax rate. The analyst further cites "encouraging" FY20 guidance, adding that the stock remains his top recommendation among U.S.financial technology, large-cap banks, specialty lenders, and asset manager companies. Fotheringham also raises his FY21 EPS view on Visa by 6c to $7.41. 10/31/19 BMOC 10/31/19 NO CHANGE Target $348 BMOC Outperform MasterCard price target raised to $348 from $328 at BMO Capital BMO Capital analyst James Fotheringham raised his price target on MasterCard (MA) to $348 and kept his Outperform rating after its "broad-based" Q3 earnings beat. The analyst believes that the company can grow its revenue faster than previously expected given its exposure to fast-growing international markets, B2B payment flows, and cross-border volume, offsetting its indicated higher marketing spend. Fotheringham prefers Visa (V) to MasterCard however due to a relative valuation discount. 11/04/19 BMOC 11/04/19 NO CHANGE Target $186 BMOC Market Perform Global Payments price target raised to $186 from $162 at BMO Capital BMO Capital analyst James Fotheringham raised his price target on Global Payments (GPN) to $186 after its Q3 revenue beat driven by better margin and stronger growth in Europe in spite of the Brexit related concerns. The analyst adds that while the company also provided higher synergy targets, he is keeping his Market Perform rating on the stock with preference toward Visa (V), MasterCard (MA), and PayPal (PYPL) due to more attractive valuations. MA MasterCard $279.01 1.9 (0.69%) 09/16/19 MSCO 09/16/19 NO CHANGE Target $315 MSCO Overweight MasterCard price target raised to $315 from $291 at Morgan Stanley Morgan Stanley analyst James Faucette raised his price target on MasterCard shares to $315 from $291 following the company's Investment Community Meeting last week. The intra-quarter data shared by the company should ease some near-term macro concerns and the event left him feeling confident in "the key pillars" of his Overweight thesis, Faucette tells investors. MasterCard is also making notable progress on its longer term initiatives, which should support growth beyond the company's 3-year outlook, added Faucette. 10/01/19 ADAM 10/01/19 NO CHANGE Target $118 ADAM Buy PayPal payment processor deal beats card networks to China, says Canaccord Canaccord analyst Joseph Vafi said Paypal's (PYPL) disclosure of its controlling stake in Chinese payment player GoPay has material strategic implications longer term. The analyst notes the deal allowed PayPal to beat both Visa (V) and Mastercard (MA) into the Chinese market and could be a conduit to drive meaningful cross-border payments volume allowing it to continue to sustain mid 20% payment volume for the next several years. Vafi reiterated his Buy rating and $118 price target on PayPal shares.

2019-11-13 11:33:35

Visa

$179.73: -0.06 (-0.03%)

, MA

MasterCard

$279.01: 1.9 (0.69%)

11:33

11/13/19

11/13

11:33

11/13/19

11:33

FTC probing Visa, MasterCard over debit card transactions, Bloomberg reports

The Federal Trade Commission, as part of a preliminary inquiry, has been reaching out to large merchants and their trade groups over Visa's (V) and Mastercard's (MA) policies that can prohibit merchants from routing card transactions over alternative debit networks, Jenny Surane of Bloomberg reports, citing people with knowledge of the matter. At issue is whether Visa and Mastercard and large debit card issuers are blocking retailers from routing some mobile wallet payments and tap-to-pay transactions over alternative networks such as Pulse, NYCE and Star, sources told Bloomberg.

Visa

$179.73: -0.06 (-0.03%)

MasterCard

$279.01: 1.9 (0.69%)

10
Dec

V Visa

$179.73: -0.06 (-0.03%)

10/25/19: JEFF

10/28/19: BMOC

10/31/19: BMOC

11/04/19: BMOC

MA MasterCard

$279.01: 1.9 (0.69%)

09/16/19: MSCO

10/01/19: ADAM

TODAY'S FREE FLY STORIES

PRSC Providence Service $57.58 -0.39 (-0.67%) 13:06 12/05/19 12/05 13:06 12/05/19 13:06 Hot Stocks	LogistiCare to provide NEMT brokerage services to certain CCO members » PacificSource Community… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
BIIB Biogen $298.02 8.67 (3.00%) 13:06 12/05/19 12/05 13:06 12/05/19 13:06 Recommendations	Biogen analyst commentary » Stifel still sees lower… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	05 Dec 05 Dec 05 Dec
SAGE Sage Therapeutics $62.50 -86.72 (-58.12%) 12:55 12/05/19 12/05 12:55 12/05/19 12:55 Downgrade	Sage Therapeutics rating change » Sage Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
STZ Constellation Brands $181.49 -2.79 (-1.51%) 12:55 12/05/19 12/05 12:55 12/05/19 12:55 Options	Constellation Brands put volume heavy and directionally bearish » Bearish flow noted in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	08 Jan
12:55 12/05/19 12/05 12:55 12/05/19 12:55 General news	Atlanta Fed's Q4 GDP Nowcast now projects a 1.48% growth rate » Atlanta Fed's Q4 GDP… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial

BIG Big Lots $18.89 -1.03 (-5.17%) , GCO Genesco $37.08 0.52 (1.42%) 12:51 12/05/19 12/05 12:51 12/05/19 12:51 Earnings	Notable companies reporting before tomorrow's open » Notable companies… BIG Big Lots $18.89 -1.03 (-5.17%) GCO Genesco $37.08 0.52 (1.42%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	06 Dec 06 Dec
CLDR Cloudera $9.86 (0.00%) , OKTA Okta $120.39 -1.43 (-1.17%) … 12:51 12/05/19 12/05 12:51 12/05/19 12:51 Earnings	Notable companies reporting after market close » Notable companies… Notable companies reporting after the market close, with earnings consensus, include Cloudera (CLDR), consensus (6c)... Okta (OKTA), consensus (12c)... Ulta Beauty (ULTA), consensus $2.13... DocuSign (DOCU), consensus 3c... Zoom Video (ZM), consensus 3c. CLDR Cloudera $9.86 (0.00%) OKTA Okta $120.39 -1.43 (-1.17%) ULTA Ulta Beauty $237.92 -1.44 (-0.60%) DOCU DocuSign $69.41 -0.565 (-0.81%) ZM Zoom Video $70.00 0.05 (0.07%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	05 Dec 05 Dec 05 Dec 05 Dec 05 Dec 09 Dec 09 Dec 16 Dec
ARQL ArQule $9.59 0.275 (2.95%) 12:45 12/05/19 12/05 12:45 12/05/19 12:45 Options	ArQule call volume above normal and directionally bullish » Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	07 Dec 09 Dec 09 Dec 09 Dec
MMM 3M $163.96 -3.145 (-1.88%) 12:32 12/05/19 12/05 12:32 12/05/19 12:32 Hot Stocks	Breaking Hot Stocks news story on 3M » 3M shares down 2% after… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	10 Dec
MMM 3M $163.96 -3.145 (-1.88%) 12:31 12/05/19 12/05 12:31 12/05/19 12:31 Hot Stocks	3M CFO says Q4 'looks a lot like Q3,' some 'hopefulness' around end markets » CFO Michael Roman says he… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	10 Dec

AXTA Axalta Coating $30.13 0.54 (1.82%) 12:25 12/05/19 12/05 12:25 12/05/19 12:25 Options	Axalta Coating call volume above normal and directionally bullish » Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
GM General Motors $35.30 0.25 (0.71%) , TSLA Tesla $330.39 -2.78 (-0.83%) 12:25 12/05/19 12/05 12:25 12/05/19 12:25 Periodicals	GM CEO sees big opportunity in all-electric pickup trucks, CNBC reports » General Motors (GM) CEO… GM General Motors $35.30 0.25 (0.71%) TSLA Tesla $330.39 -2.78 (-0.83%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	05 Dec 07 Jan
HOV Hovnanian $24.73 3.39 (15.89%) 12:23 12/05/19 12/05 12:23 12/05/19 12:23 Earnings	Hovnanian surges 15% after Q4 report, revenue and deliveries climb » Shares of home-builder… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	05 Dec
$NSD NASDAQ Market Internals $0.00 (0.00%) 12:17 12/05/19 12/05 12:17 12/05/19 12:17 Technical Analysis	NASDAQ market internals summary » Volume is average for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
$NYE NYSE Market Internals $0.00 (0.00%) 12:16 12/05/19 12/05 12:16 12/05/19 12:16 Technical Analysis	NYSE market internals summary » Volume is below average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

LUV Southwest $55.72 -0.05 (-0.09%) 12:15 12/05/19 12/05 12:15 12/05/19 12:15 Options	Southwest put volume heavy and directionally bearish » Bearish flow noted in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	05 Dec 12 Dec 23 Jan
SIGA Siga Technologies $4.39 -0.01 (-0.23%) 12:13 12/05/19 12/05 12:13 12/05/19 12:13 Hot Stocks	Siga announces CDND intent to purchase up to 15,325 courses of oral TPOXX » SIGA Technologies… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
OPRT Oportun Financial $20.06 0.04 (0.20%) 12:11 12/05/19 12/05 12:11 12/05/19 12:11 Conference/Events	Oportun Financial management to meet with Jefferies » Meeting to be held in Los… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	06 Dec
GALT Galectin Therapeutics $2.98 -0.06 (-1.97%) 12:09 12/05/19 12/05 12:09 12/05/19 12:09 Hot Stocks	Galectin Therapeutics plans adaptively designed Phase 3 NASH-RX trial » Galectin Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
BA Boeing $348.04 -0.85 (-0.24%) 12:09 12/05/19 12/05 12:09 12/05/19 12:09 Periodicals	Boeing to SEC: Doesn't see 737 MAX cancellations impacting revenue, Reuters says » In a letter to the SEC,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

MASI Masimo $156.34 -1.11 (-0.70%) 12:05 12/05/19 12/05 12:05 12/05/19 12:05 Conference/Events	Masimo management to meet with Piper Jaffray » Meeting to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec
ACHN Achillion $6.16 -0.025 (-0.40%) 12:05 12/05/19 12/05 12:05 12/05/19 12:05 Options	Achillion call volume above normal and directionally bullish » Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	07 Dec 19 Dec
TVTY Tivity Health $22.60 -0.23 (-1.01%) 12:04 12/05/19 12/05 12:04 12/05/19 12:04 Conference/Events	Tivity Health management to meet with Piper Jaffray » Meeting to be held in New… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	10 Dec
MIC Macquarie Infrastructure $42.49 0.43 (1.02%) 12:04 12/05/19 12/05 12:04 12/05/19 12:04 Conference/Events	Macquarie Infrastructure management to meet with Suntrust » Group Dinner with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	11 Dec
TCBK TriCo Bancshares $38.57 0.09 (0.23%) 12:03 12/05/19 12/05 12:03 12/05/19 12:03 Conference/Events	TriCo Bancshares management to meet with Piper Jaffray » Meetings to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	09 Dec 09 Dec 10 Dec 10 Dec 11 Dec 11 Dec

Events

Earnings calls, analyst events, roadshows and more

TD
Today at 13:30

Toronto-Dominion - TD Conference Calls
Today at 14:00

Examination of the FHA Government Event

Room 2128 Rayburn House Office Building, Washington, D.C.
Today at 14:00

Healthcare/Biotech Industry Meetings
Today at 14:00

Technology Industry Meetings
LFVN
Today at 15:00

Lifevantage Corp Firm Sponsored Meetings

9685 South Monroe Street, Sandy, UT
Today at 16:30

Fed Balance Sheet Level: Week 12/4/19 Government Event
Today at 16:30

Fed Balance Sheet Total Assets W/W: Week 12/4/19 Government Event
Today at 16:30

Fed Balance Sheet Reserve Bank Credit W/W: Week 12/4/19 Government Event
Today at 16:30

Money Supply: M2 Weekly Change: Week 11/25/19 Government Event
RTW
Today at 16:30

RTW Retailwinds - RTW Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	ELF X ELF e.l.f. Beauty Block Trade Managers: Morgan Stanley Priced at: $15.90 3.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AER X AER AerCap Spot Secondary Managers: Citi Priced at: $60.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CWEN X CWEN Clearway Energy Spot Secondary Managers: RBC Capital Priced at: $18.70 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FSV X FSV FirstService Spot Secondary Managers: BMO Capital & TD Securities Priced at: $92.50 2.165M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	ARWR X ARWR Arrowhead Secondary Managers: Goldman Sachs, Jefferies, Piper Jaffray & Cantor Fitzgerald, Baird, B. Riley FBR Priced at: $58.00 4M Shares KOD X KOD Kodiak Sciences Secondary Managers: JPMorgan, Goldman Sachs & Jefferies Priced at: $46.00 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRAY X VRAY ViewRay Secondary Managers: Piper Jaffray Priced at: $3.13 41.55M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CNNE X CNNE Cannae Holdings Spot Secondary Managers: BofA/Merrill & Stephens Priced at: $33.00 6.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLMD X RLMD Relmada Therapeutics Spot Secondary Managers: Jefferies, SVB Leerink & Guggenheim Priced at: $30.00 3.333M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RVNC X RVNC Revance Spot Secondary Managers: Cowen, Piper Jaffray & Stifel Priced at: $17.00 6.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	LMPX X LMPX LMP Automotive IPO Managers: ThinkEquity Priced at: $5.00 2.3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CCC X CCC Clarivate Analytics Secondary Managers: Citi & Goldman Sachs Priced at: $17.25 43.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial IMMU X IMMU Immunomedics Secondary Managers: Goldman Sachs, BofA/Merrill, Cowen & Jefferies Priced at: $17.50 14.29M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TUFN X TUFN Tufin Secondary Managers: JPMorgan, Barclays & Jefferies, Oppenheimer, Baird, Piper Jaffray, Stifel, William Blair Priced at: $17.00 4.28M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ARDX X ARDX Ardelyx Spot Secondary Managers: Citi, Cowen, SVB Leerink & Piper Jaffray Priced at: $6.25 20M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MLND X MLND Millendo Therapeutics Spot Secondary Managers: Citi & SVB Leerink Priced at: $6.00 4.167M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NJR X NJR New Jersey Resources Spot Secondary Managers: Wells Fargo & JPMorgan, BBNT, TD Securities, Goldman Sachs, Janney Montgomery Scott, Siebert Williams Priced at: $41.25 5.7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OMER X OMER Omeros Spot Secondary Managers: Cantor Fitzgerald Priced at: $13.10 3.816M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RC X RC Ready Capital Spot Secondary Managers: Morgan Stanley, UBS, Wells Fargo & Keefe Bruyette Priced at: $15.58 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial WHF X WHF WhiteHorse Finance Spot Secondary Managers: Raymond James, Keefe Bruyette & Deutsche Bank, Ladenburg, Oppenheimer, B. Riley FBR, National Securities Priced at: $13.83 2.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $13.25 11.18M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EVOP X EVOP EVO Payments Spot Secondary Managers: JPMorgan & Barclays Priced at: $27.60 4.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	DT X DT Dynatrace Secondary Managers: Goldman Sachs, JPMorgan, Citi, RBC Capital, BofA/Merrill, Barclays, UBS & Jefferies, Canaccord, WBLR BTIG, JMP Securities, KeyBanc, Raymond James, Academy Securities $27.02 27.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EVRI X EVRI Everi Holdings Secondary Managers: Jefferies, Stifel, Craig-Hallum & Raymond James, SunTrust $12.88 10M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GDS X GDS GDS Holdings Secondary Managers: JPMorgan, RBC Capital & BofA/Merrill, Haitong International $45.27 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLUG X PLUG Plug Power Secondary Managers: Morgan Stanley & Barclays $3.80 40M Shares TTEC X TTEC TTEC Holdings Secondary Managers: BofA/Merrill, Morgan Stanley, Cowen, Craig-Hallum & William Blair, Northland, HSBC $44.71 3M Shares
Fri	No deals

View All Syndicate Announcements »

FTC probing Visa, MasterCard over debit card transactions, Bloomberg reports

TODAY'S FREE FLY STORIES

Get Full Fly Access